Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2025-12-25 @ 7:18 PM
NCT ID: NCT03319732
Description: None
Frequency Threshold: 5
Time Frame: 60 weeks
Study: NCT03319732
Study Brief: A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AERT 80 mg Arbaclofen extended release tablet, 20 mg 1 None 21 323 278 323 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Acute Myocardial Infarction SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (20.1) View
Myocardial Infarction SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (20.1) View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (20.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (20.1) View
Pancreatitis chronic SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (20.1) View
Cholecystitis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA (20.1) View
Osteomyelitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (20.1) View
Toxicity to various agents SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (20.1) View
Meningioma SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (20.1) View
Adenocarcinoma of colon SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (20.1) View
Multiple Sclerosis relapse SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.1) View
Paraparesis SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.1) View
Restless Legs Syndrome SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.1) View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.1) View
Atonic Urinary Bladder SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (20.1) View
Decubitus Ulcer SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (20.1) View
Dermatitis Allergic SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (20.1) View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (20.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (20.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.1) View
Urinary Tract Disorder SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (20.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (20.1) View
Asthenia SYSTEMATIC_ASSESSMENT General disorders MedDRA (20.1) View
Gait Disturbance SYSTEMATIC_ASSESSMENT General disorders MedDRA (20.1) View
Muscular Weakness SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (20.1) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.1) View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.1) View